"Kyowa Hakko Kirin Co., Ltd. - Product Pipeline Review - 2012" Published -- Fast Market Research, Inc.

Oct. 19, 2012 - PRLog -- Global Market Direct's pharmaceuticals report, "Kyowa Hakko Kirin Co., Ltd. - Product Pipeline Review - 2012" provides data on the Kyowa Hakko Kirin Co., Ltd.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Kyowa Hakko Kirin Co., Ltd.'s corporate website, SEC filings, investor presentations and featured press releases, both from Kyowa Hakko Kirin Co., Ltd. and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

* Kyowa Hakko Kirin Co., Ltd. - Brief Kyowa Hakko Kirin Co., Ltd. overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline of Kyowa Hakko Kirin Co., Ltd. human therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Kyowa Hakko Kirin Co., Ltd. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Kyowa Hakko Kirin Co., Ltd.'s pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.

------------------------------------------------------------
Full Report Details at
- http://www.fastmr.com/prod/468495_kyowa_hakko_kirin_co_lt...
------------------------------------------------------------

Reasons to buy

* Evaluate Kyowa Hakko Kirin Co., Ltd.'s strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Kyowa Hakko Kirin Co., Ltd. in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Kyowa Hakko Kirin Co., Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Kyowa Hakko Kirin Co., Ltd..
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Kyowa Hakko Kirin Co., Ltd. and identify potential opportunities in those areas.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Kyowa Hakko Kirin Co., Ltd. Snapshot
Kyowa Hakko Kirin Co., Ltd. Overview
Key Information
Key Facts
Kyowa Hakko Kirin Co., Ltd. - Research and Development Overview
Key Therapeutic Areas
Kyowa Hakko Kirin Co., Ltd. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Combination Treatment Modalities
Kyowa Hakko Kirin Co., Ltd. - Pipeline Products Glance
Kyowa Hakko Kirin Co., Ltd. - Late Stage Pipeline
Kyowa Hakko Kirin Co., Ltd. Clinical Stage Pipeline Products
Kyowa Hakko Kirin Co., Ltd. - Early Stage Pipeline Products
Kyowa Hakko Kirin Co., Ltd. - Drug Profiles
ARQ 197 + Erlotinib
ASKP-1240
bardoxolone methyl
brodalumab
darbepoetin alfa
fentanyl citrate
istradefylline
KHK-6188
KRN-23
KRN-330
KRN330 + Irinotecan
KW-0761 + mLSG15
KW-2450
KW-2450 + Lapatinib + Letrozole
KW-2478
KW-2478 + Bortezomib
KW-3357
KW-6356
litronesib
LY2523355 + Pegfilgrastim
MEDI-563
mogamulizumab
Onglyza
pegfilgrastim
salinomycin
tivantinib
tivozanib
topiramate
Kyowa Hakko Kirin Co., Ltd. - Pipeline Products by Route of Administration
Kyowa Hakko Kirin Co., Ltd. - Pipeline Products By Mechanism of Action
Kyowa Hakko Kirin Co., Ltd. - Recent Pipeline Updates
Kyowa Hakko Kirin Co., Ltd. - Dormant Projects
Kyowa Hakko Kirin Co., Ltd. - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
Kyowa Hakko Kirin Co., Ltd. - Company Statement
Kyowa Hakko Kirin Co., Ltd. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Kyowa Hakko Kirin Co., Ltd., Recent Developments
Kyowa Hakko Kirin Co., Ltd.- Press Release
Financial Deals Landscape
Kyowa Hakko Kirin Co., Ltd., Deals Summary
Kyowa Hakko Kirin Co., Ltd., Pharmaceuticals & Healthcare, Deal Details
Asset Transactions
Venture Financing
Partnerships
Licensing Agreements
Equity Offering
Asset Transactions
Acquisition
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Kyowa Hakko Kirin Co., Ltd., Key Information
Kyowa Hakko Kirin Co., Ltd., Key Facts
Kyowa Hakko Kirin Co., Ltd. - Pipeline by Indication, 2012
Kyowa Hakko Kirin Co., Ltd. - Pipeline by Stage of Development, 2012
Kyowa Hakko Kirin Co., Ltd. - Monotherapy Products in Pipeline, 2012
Kyowa Hakko Kirin Co., Ltd. - Combination Treatment Modalities in Pipeline, 2012
Kyowa Hakko Kirin Co., Ltd. - Filed, 2012
Kyowa Hakko Kirin Co., Ltd. - Phase III, 2012
Kyowa Hakko Kirin Co., Ltd. - Phase II, 2012
Kyowa Hakko Kirin Co., Ltd. - Phase I, 2012
Kyowa Hakko Kirin Co., Ltd. - Pre-Clinical, 2012
Kyowa Hakko Kirin Co., Ltd. - Pipeline By Route of Administration, 2012
Kyowa Hakko Kirin Co., Ltd. - Pipeline Products By Mechanism of Action, 2012
Kyowa Hakko Kirin Co., Ltd. - Recent Pipeline Updates, 2012
Kyowa Hakko Kirin Co., Ltd. - Dormant Developmental Projects,2012
Kyowa Hakko Kirin Co., Ltd. - Discontinued Pipeline Products, 2012

Full Table of Contents is available at:
-- http://www.fastmr.com/catalog/product.aspx?productid=4684...

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.

End